{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:34:44Z","timestamp":1789169684092,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-MSLH-170"],"award-info":[{"award-number":["2024-MSLH-170"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.phrs.2025.107783","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T02:42:48Z","timestamp":1747276968000},"page":"107783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Paclitaxel-Ang-2-functionalized bionic mesoporous selenium nanoparticles for targeted therapy of glioma"],"prefix":"10.1016","volume":"216","author":[{"given":"Huan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biaobiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2025.107783_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00415-017-8695-5","article-title":"Advances in immunotherapeutic research for glioma therapy","volume":"265","author":"Miyauchi","year":"2018","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12964-021-00777-0","article-title":"Opportunities and challenges of glioma organoids","volume":"19","author":"Xu","year":"2021","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"10","key":"10.1016\/j.phrs.2025.107783_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103735","article-title":"Recent advances towards overcoming the blood-brain barrier","volume":"28","author":"Ali","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.phrs.2025.107783_bib6","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3390\/biomedicines12102302","article-title":"The mechanism and latest research progress of blood-brain barrier breakthrough","volume":"12","author":"Wang","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.phrs.2025.107783_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107783_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1039\/C5BM00383K","article-title":"Strategies for transporting nanoparticles across the blood-brain barrier","volume":"4","author":"Zhang","year":"2016","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107783_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.phrs.2025.107783_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.phrs.2025.107783_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12249-024-02810-0","article-title":"In-depth mechanism, challenges, and opportunities of delivering therapeutics in brain using intranasal route","volume":"25","author":"Ghosh","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.phrs.2025.107783_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2025.107783_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216166","article-title":"Barrier permeation and improved nanomedicine delivery in tumor microenvironments","volume":"562","author":"Liu","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"issue":"16","key":"10.1016\/j.phrs.2025.107783_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202200048","article-title":"A transformable amphiphilic and block polymer-dendron conjugate for enhanced tumor penetration and retention with cellular homeostasis perturbation via membrane flow","volume":"34","author":"Gu","year":"2022","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.phrs.2025.107783_bib16","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.1021\/acsnano.3c03195","article-title":"Reactive oxygen species-sensitive biodegradable mesoporous silica nanoparticles harboring theravac elicit tumor-specific immunity for colon tumor treatment","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2025.107783_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118365","article-title":"A dandelion polysaccharide and its selenium nanoparticles: structure features and evaluation of anti-tumor activity in zebrafish models","volume":"270","author":"Zhang","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"7","key":"10.1016\/j.phrs.2025.107783_bib18","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1007\/s10439-019-02384-0","article-title":"Emerging biomimetic materials for studying tumor and immune cell behavior","volume":"48","author":"Northcutt","year":"2020","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.phrs.2025.107783_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154014","article-title":"Biosynthesis and cytotoxic effect of silymarin-functionalized selenium nanoparticles induced autophagy mediated cellular apoptosis via downregulation of PI3K\/Akt\/mTOR pathway in gastric cancer","volume":"99","author":"Mi","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.107783_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120253","article-title":"Hierarchically constructed selenium-doped bone-mimetic nanoparticles promote ROS-mediated autophagy and apoptosis for bone tumor inhibition","volume":"257","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2025.107783_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jcis.2021.02.098","article-title":"Engineering of dendritic mesoporous silica nanoparticles for efficient delivery of water-insoluble paclitaxel in cancer therapy","volume":"593","author":"Deng","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.phrs.2025.107783_bib22","article-title":"Porous selenium nanozymes targeted scavenging ROS synchronize therapy local inflammation and sepsis injury","volume":"22","author":"Xu","year":"2021","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.phrs.2025.107783_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.actbio.2017.02.042","article-title":"Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity","volume":"54","author":"Zhao","year":"2017","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.phrs.2025.107783_bib24","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.msec.2013.01.045","article-title":"Nano-magnetic particles used in biomedicine: core and coating materials","volume":"33","author":"Karimi","year":"2013","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"49","key":"10.1016\/j.phrs.2025.107783_bib25","doi-asserted-by":"crossref","first-page":"58401","DOI":"10.1021\/acsami.1c18941","article-title":"Effect of nanoparticle synthetic conditions on ligand coating integrity and subsequent nano-biointeractions","volume":"13","author":"Hsu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.phrs.2025.107783_bib26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1039\/C9BM01392J","article-title":"Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12951-021-01085-y","article-title":"Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13058-024-01853-2","article-title":"Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer","volume":"26","author":"Du","year":"2024","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2025.107783_bib29","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00216-010-4124-7","article-title":"Selective recognition of a saccharide-type tumor marker with natural and synthetic ligands: a new trend in cancer diagnosis","volume":"398","author":"Kej\u00edk","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.phrs.2025.107783_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116893","article-title":"Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma","volume":"69","author":"Yang","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107783_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2018.07.055","article-title":"pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma","volume":"124","author":"Li","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2025.107783_bib32","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.18632\/aging.103275","article-title":"Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.phrs.2025.107783_bib33","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1021\/acs.molpharmaceut.8b01056","article-title":"Angiopep-2-conjugated \"core-shell\" hybrid nanovehicles for targeted and ph-triggered delivery of arsenic trioxide into glioma","volume":"16","author":"Tao","year":"2019","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2025.107783_bib34","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1021\/acsami.3c14709","article-title":"Angiopep-2-functionalized lipid cubosomes for blood-brain barrier crossing and glioblastoma treatment","volume":"16","author":"Cai","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.phrs.2025.107783_bib35","first-page":"4402","article-title":"Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma","volume":"6","author":"Fan","year":"2021","journal-title":"Bioact. Mater."},{"issue":"2","key":"10.1016\/j.phrs.2025.107783_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1158\/1078-0432.CCR-19-2182","article-title":"Ultrasound-mediated delivery of paclitaxel for glioma: a comparative study of distribution, toxicity, and efficacy of albumin-bound versus cremophor formulations","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2025.107783_bib37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41419-024-07228-x","article-title":"Amantadine against glioma via ROS-mediated apoptosis and autophagy arrest","volume":"15","author":"Luo","year":"2024","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.phrs.2025.107783_bib38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107783_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41419-024-06653-2","article-title":"Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate","volume":"15","author":"Marrocco","year":"2024","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.phrs.2025.107783_bib40","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1021\/nn504210g","article-title":"Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration","volume":"8","author":"Nance","year":"2014","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.phrs.2025.107783_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/1061186X.2022.2119243","article-title":"Progress in research and development of temozolomide brain-targeted preparations: a review","volume":"31","author":"Yang","year":"2023","journal-title":"J. Drug Target"},{"key":"10.1016\/j.phrs.2025.107783_bib42","article-title":"Trends and recent progresses of selenium nanoparticles as novel autophagy regulators for therapeutic development","volume":"10","author":"Chen","year":"2023","journal-title":"Front. Nutr."},{"issue":"7","key":"10.1016\/j.phrs.2025.107783_bib43","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1007\/s12011-023-03886-8","article-title":"Cross-Talk between Selenium Nanoparticles and Cancer Treatment through Autophagy","volume":"202","author":"Ali","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12896-024-00915-9","article-title":"Biosafety and pharmacokinetic characteristics of polyethylene pyrrolidone modified nano selenium in rats","volume":"24","author":"Li","year":"2024","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.phrs.2025.107783_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120253","article-title":"Hierarchically constructed selenium-doped bone-mimetic nanoparticles promote ROS-mediated autophagy and apoptosis for bone tumor inhibition","volume":"257","author":"Li","year":"2020","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.phrs.2025.107783_bib46","doi-asserted-by":"crossref","first-page":"9927","DOI":"10.1021\/acsnano.6b03835","article-title":"In vitro and in vivo mechanism of bone tumor inhibition by selenium-doped bone mineral nanoparticles","volume":"10","author":"Wang","year":"2016","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.phrs.2025.107783_bib47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12951-022-01576-6","article-title":"Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K\/Akt\/mTOR signaling pathway","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."}],"updated-by":[{"DOI":"10.1016\/j.phrs.2025.107824","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:46:42Z","timestamp":1762354002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825002087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S1043661825002087"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107783","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel-Ang-2-functionalized bionic mesoporous selenium nanoparticles for targeted therapy of glioma","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107783"}}